Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.1M Buy
318,417
+101
+0% +$6.13K 0.11% 159
2026
Q1
$15.6M Sell
318,316
-159,342
-33% -$7.44M 0.08% 187
2025
Q4
$17.2M Buy
477,658
+76,540
+19% +$3.1M 0.09% 177
2025
Q3
$18.3M Buy
+401,118
New +$16.2M 0.1% 176
2022
Q2
Sell
-4,124
Closed -$318K 1002
2022
Q1
$318K Hold
4,124
﹤0.01% 850
2021
Q4
$321K Sell
4,124
-17
-0.4% -$1.37K ﹤0.01% 888
2021
Q3
$332K Buy
4,141
+426
+11% +$36.7K ﹤0.01% 829
2021
Q2
$312K Buy
+3,715
New +$301K ﹤0.01% 772

Other funds holding CGNX

Davenport & Co's CGNX Position: Q2 2026 in Review

Davenport & Co increased its Cognex (CGNX) stake by 0.03% in Q2 2026, buying an estimated $6.13K and bringing the position to 318,417 shares worth $23.1M. The position accounts for 0.11% of the portfolio, ranked #159.

Davenport & Co first reported a position in CGNX in Q2 2021 and has held it in 8 quarters since. 653 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Davenport & Co held 318,417 shares of Cognex worth $23.1M as of Q2 2026.
  • Davenport & Co bought 101 Cognex shares in Q2 2026, an estimated $6.13K.
  • Cognex made up 0.11% of Davenport & Co's portfolio in Q2 2026, its #159 holding.
  • Davenport & Co first reported a position in Cognex in Q2 2021 and has held it in 8 quarters since.
  • 653 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.